04-07-2013 12:23

SOPHARMA AD - Current report 91 Lavena AD above 5% (91/2013)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No	91	/	2013
Date of issue:	2013-07-04
Short name of the issuer
SOPHARMA AD
Subject
Current report 91 Lavena AD above 5%
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the ?Company") announces that on 18 June 2013 the Company bought 4 039 from the capital increase of Lavena AD. After this transaction, the share of Sopharma AD in the capital of Lavena AD increased to 5.18%.
Annexes
File	Description
Current report 91 Lavena AD above 5%.doc	Current report 91 Lavena AD above 5%

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

| | | SOPHARMA AD | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | SOPHARMA AD | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 1220 | | Sofia | | | |
| | | (post code) | | (city) | | | |
| | | IlienskoShosse | | 16 | | | |
| | | (street) | | (number) | | | |
| | | +359 2 813 42 00 | | +359 2 936 02 86 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nd | | | | | |
| | | (NIP)
| | | (REGON) | | |

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2013-07-04	Ognian Donev	Executive Director

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Oceń jakość naszego artykułu:

Twoja opinia pozwala nam tworzyć lepsze treści.

WP Finanse na:

Instagramie

👍Lubię to!

Komentarze

Trwa ładowanie